A detailed history of Fortitude Family Office, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Fortitude Family Office, LLC holds 824 shares of EXAS stock, worth $55,232. This represents 0.02% of its overall portfolio holdings.

Number of Shares
824
Previous 829 0.6%
Holding current value
$55,232
Previous $45.4 Million 84.51%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

SELL
$56.19 - $69.63 $280 - $348
-5 Reduced 0.6%
824 $83.7 Million
Q3 2025

Oct 17, 2025

BUY
$40.91 - $56.0 $245 - $336
6 Added 0.73%
829 $45.4 Million
Q2 2025

Jul 14, 2025

BUY
$40.31 - $58.08 $927 - $1,335
23 Added 2.88%
823 $43.7 Million
Q1 2024

Apr 11, 2024

BUY
$56.27 - $73.77 $45,016 - $59,016
800 New
800 $55.2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Fortitude Family Office, LLC Portfolio

Follow Fortitude Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Family Office, LLC with notifications on news.